The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 53 (3) , 460-468
- https://doi.org/10.1016/s0015-0282(16)53341-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Are fixed‐dose oestrogen/progestogen combinations ideal for all HRT users?BJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Gynecologic consequences of long-term, unopposed estrogen replacement therapyMaturitas, 1988
- Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.Circulation, 1987
- Controversies concerning the safety of estrogen replacement therapyAmerican Journal of Obstetrics and Gynecology, 1987
- A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving EstrogensNew England Journal of Medicine, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976